Abstract
Combination therapy with anti-cytotoxic T lymphocyte-associated protein 4 (CTLA-4) and anti-programmed death-1 (PD-1) monoclonal antibodies (mAbs) has......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
